ClickCease vs Oxylabs: Revenue, Funding & Team Size Compared
ClickCease has not disclosed its revenue; Oxylabs generates $350M. The table below compares ClickCease and Oxylabs on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  ClickCeaseThis company |  Oxylabs |
|---|---|---|
| Revenue | Not disclosed | $350M |
| Funding raised | Not disclosed | $130M |
| Team size | Not disclosed | 397 |
| Growth | Not disclosed | 701.5% |
| Founded | 2014 | Not disclosed |
| HQ | Tel Aviv, Israel | Vilnius, Lithuania |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
ClickCease at a glance
- Founded
- 2014
ClickCease is a click-fraud detection and protection software that prevents bots and competitors from wasting PPC advertising budgets.
Oxylabs at a glance
Oxylabs generates $350M in revenue with 397 employees, headquartered in Vilnius, Lithuania.
- Revenue
- $350M
- Funding
- $130M
- Team size
- 397
🌐 Unlocking the Power of Web Intelligence with Oxylabs! We're on a mission to empower businesses of all sizes with the priceless resource of publicly available data. In an era where data drives success, we're dedicated to ensuring that…
Other ClickCease alternatives
ClickCease competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
ClickCease vs Oxylabs: frequently asked questions
How much revenue does Oxylabs make?
Oxylabs generates $350M in annual revenue with a team of 397.
How much funding has Oxylabs raised?
Oxylabs has raised $130M in total funding.